Quality use of medicines: Weighing SSRIs and TCAs

  • Andy Gray University of Natal

Abstract

The review was prompted by a comment on the E-DRUG list after the recent launch of the 13th World Health Organization Model Essential Medicines List. The author, an Oxford academic, noted that amitriptyline remained the only listed antidepressant and expressed the view that 'one of the SSRIs (selective scrotonim reuptake inhibitors) should have been included because of their superiority in terms of side effects, although not in efficacy.

Author Biography

Andy Gray, University of Natal
Department of Experimental and Clinical Pharmacology Nelson R Mandela School of Medicine
Section
CPD